We analyzed seven commonly studied prostate cancer cell lines, representing CSPC (LNCaP, LAPC‐4, VCaP), AR‐driven/adenocarcinoma CRPC (LNCaP‐abl, LREX’), and non‐AR‐driven CPRC (DU145, PC3). This evidence concerns the gene AR and prostate carcinoma.